Art

J-GLOBAL ID：201902258753150867   Reference number：19A1480569

Antifibrotic effects of 2-carba cyclic phosphatidic acid (2ccPA) in systemic sclerosis: contribution to the novel treatment

全身性硬化症における2-カルバ環状ホスファチジン酸(2CCPA)の抗線維症効果:新規治療への寄与【JST・京大機械翻訳】

Author (10)： Higuchi Tomoaki (Department of Rheumatology, Tokyo Women’s Medical University School of Medicine, Tokyo, Japan) ,  Takagi Kae (Department of Rheumatology, Tokyo Women’s Medical University School of Medicine, Tokyo, Japan) ,  Tochimoto Akiko (Department of Rheumatology, Tokyo Women’s Medical University School of Medicine, Tokyo, Japan) ,  Ichimura Yuki (Department of Rheumatology, Tokyo Women’s Medical University School of Medicine, Tokyo, Japan) ,  Norose Takanari (Department of Rheumatology, Tokyo Women’s Medical University School of Medicine, Tokyo, Japan) ,  Katsumata Yasuhiro (Department of Rheumatology, Tokyo Women’s Medical University School of Medicine, Tokyo, Japan) ,  Masuda Ikuko (Department of Rheumatology, Tokyo Women’s Medical University School of Medicine, Tokyo, Japan) ,  Yamanaka Hisashi (Department of Rheumatology, Tokyo Women’s Medical University School of Medicine, Tokyo, Japan) ,  Morohoshi Toshiro (SANSHO, Co., Ltd., Tokyo, Japan) ,  Kawaguchi Yasushi (Department of Rheumatology, Tokyo Women’s Medical University School of Medicine, Tokyo, Japan)
Material： Arthritis Research & Therapy (Web)
Volume： 21  Issue： 1  Page： 103  Publication year： 2019 
JST Material Number： U7412A  ISSN： 1478-6362  Document type： Article
Article type： 原著論文  Country of issue： United Kingdom (GBR)  Language： ENGLISH (EN)

Abstract/Point： Cyclic phosphatidic acid (cPA)...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=19A1480569&from=J-GLOBAL&jstjournalNo=U7412A") }}

Thesaurus term： *fibrous disease ,  human(primates) ,  bleomycin ,  *therapy ,  extracellular matrix ,  fibroblast ,  adenine nucleotide ,  ribonucleotide ,  cyclic nucleotide
Semi thesaurus term： *環状ホスファチジン酸 ,  病巣 ,  抗線維化作用 ,  TGFβ1 ,  モデルマウス ,  動物モデル ,  皮膚線維芽細胞 ,  オータキシン ,  *全身性強皮症 , 【Automatic Indexing@JST】

Author keywords (5)： Fibrosis ,  Fibroblasts ,  Systemic sclerosis ,  Cyclic phosphatidic acid ,  Treatment

JST classification (3)： Basic medicine on musculoskeletal system  (GG01020B) ,  Immunological reaction in general  (ED03010T) ,  Immunologic diseases,allergic diseases in general.  (GD04010C)

Substance index (1)： cAMP

Reference (50)：

• N Engl J Med; Mechanisms of disease: scleroderma; A Gabrielli, EV Avvedimento, T Krieg; 360; 2009; 1989-2003; 10.1056/NEJMra0806188; citation_id=CR1
• J Dermatol; Mechanisms of skin fibrosis in systemic sclerosis; M Jinnin; 37; 2010; 11-25; 10.1111/j.1346-8138.2009.00738.x; citation_id=CR2
• Mod Rheumatol; Decreased expression of Runx1 and lowered proportion of Foxp3+ CD25+ CD4+ regulatory T cells in systemic sclerosis; H Kataoka, S Yasuda, S Fukaya, K Oku, T Horita, T Atsumi, T Koike; 25; 2015; 90-95; 10.3109/14397595.2014.899736; citation_id=CR3
• J Rheumatol; Evaluation of functional disability using the health assessment questionnaire in Japanese patients with systemic sclerosis; M Kuwana, S Sato, K Kikuchi, Y Kawaguchi, A Fujisaku, Y Misaki; 30; 2003; 1253-1258; citation_id=CR4
• Mod Rheumatol; What should clinicians know about the use of glucocorticoids in systemic sclerosis?; M Iudici; 6; 2017; 1-5; citation_id=CR5

Terms in the title (4)： 全身性硬化症 ,  環状ホスファチジン酸 ,  線維症 ,  治療